Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese
Obesity plays an essential role in the safety of pharmacologic drugs. There is paucity of data for direct oral anticoagulants (DOACs) in the obese, despite these agents becoming more widely used. The primary and secondary objectives of this study were to assess the safety and efficacy of DOACs in th...
Saved in:
Main Authors: | Kimberley Doucette, Hira Latif, Anusha Vakiti, Eshetu Tefera, Bhavisha Patel, Kelly Fitzpatrick |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2020/3890706 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Direct oral anticoagulants (DOACs): From the laboratory point of view
by: Margetić Sandra, et al.
Published: (2022-12-01) -
Direct-Acting Oral Anticoagulants in the Management of Cerebral Venous Sinus Thrombosis—Where Do We Stand?
by: Nikhil Vojjala, et al.
Published: (2025-01-01) -
Influence of novel oral anticoagulants on anticoagulation care management
by: Janzic Andrej, et al.
Published: (2017-09-01) -
Direct oral anticoagulants for stroke prevention and risk of bleeding
by: Tomoyuki Kawada
Published: (2025-02-01) -
Predictors of direct oral anticoagulant concentrations in the trauma population
by: Laura Adams, et al.
Published: (2024-05-01)